298 related articles for article (PubMed ID: 25048782)
1. Evolving understanding of the CLL genome.
Gruber M; Wu CJ
Semin Hematol; 2014 Jul; 51(3):177-87. PubMed ID: 25048782
[TBL] [Abstract][Full Text] [Related]
2. Genomic and epigenomic heterogeneity in chronic lymphocytic leukemia.
Guièze R; Wu CJ
Blood; 2015 Jul; 126(4):445-53. PubMed ID: 26065654
[TBL] [Abstract][Full Text] [Related]
3. Chronic lymphocytic leukemia: Time to go past genomics?
Roos-Weil D; Nguyen-Khac F; Bernard OA
Am J Hematol; 2016 May; 91(5):518-28. PubMed ID: 26800490
[TBL] [Abstract][Full Text] [Related]
4. B-cell antigen receptor expression and phosphatidylinositol 3-kinase signaling regulate genesis and maintenance of mouse chronic lymphocytic leukemia.
Schmid VK; Khadour A; Ahmed N; Brandl C; Nitschke L; Rajewsky K; Jumaa H; Hobeika E
Haematologica; 2022 Aug; 107(8):1796-1814. PubMed ID: 35021605
[TBL] [Abstract][Full Text] [Related]
5. Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease.
Rodríguez-Vicente AE; Díaz MG; Hernández-Rivas JM
Cancer Genet; 2013 Mar; 206(3):49-62. PubMed ID: 23531595
[TBL] [Abstract][Full Text] [Related]
6. The Mithralog EC-7072 Induces Chronic Lymphocytic Leukemia Cell Death by Targeting Tonic B-Cell Receptor Signaling.
Lorenzo-Herrero S; Sordo-Bahamonde C; Bretones G; Payer ÁR; González-Rodríguez AP; González-García E; Pérez-Escuredo J; Villa-Álvarez M; Núñez LE; Morís F; Gonzalez S; López-Soto A
Front Immunol; 2019; 10():2455. PubMed ID: 31681329
[TBL] [Abstract][Full Text] [Related]
7. Targeted therapy in chronic lymphocytic leukemia: past, present, and future.
Danilov AV
Clin Ther; 2013 Sep; 35(9):1258-70. PubMed ID: 24054703
[TBL] [Abstract][Full Text] [Related]
8. Novel insights into the biology of CLL.
Lanasa MC
Hematology Am Soc Hematol Educ Program; 2010; 2010():70-6. PubMed ID: 21239773
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathogenesis of CLL and its evolution.
Rodríguez D; Bretones G; Arango JR; Valdespino V; Campo E; Quesada V; López-Otín C
Int J Hematol; 2015 Mar; 101(3):219-28. PubMed ID: 25630433
[TBL] [Abstract][Full Text] [Related]
10. Multidimensional single-cell analysis of BCR signaling reveals proximal activation defect as a hallmark of chronic lymphocytic leukemia B cells.
Palomba ML; Piersanti K; Ziegler CG; Decker H; Cotari JW; Bantilan K; Rijo I; Gardner JR; Heaney M; Bemis D; Balderas R; Malek SN; Seymour E; Zelenetz AD; van den Brink MR; Altan-Bonnet G
PLoS One; 2014; 9(1):e79987. PubMed ID: 24489640
[TBL] [Abstract][Full Text] [Related]
11. Exploiting biological diversity and genomic aberrations in chronic lymphocytic leukemia.
Seiffert M; Dietrich S; Jethwa A; Glimm H; Lichter P; Zenz T
Leuk Lymphoma; 2012 Jun; 53(6):1023-31. PubMed ID: 22023519
[TBL] [Abstract][Full Text] [Related]
12. Low
Cavallini C; Chignola R; Dando I; Perbellini O; Mimiola E; Lovato O; Laudanna C; Pizzolo G; Donadelli M; Scupoli MT
Blood; 2018 Apr; 131(17):1942-1954. PubMed ID: 29467184
[TBL] [Abstract][Full Text] [Related]
13. Stereotyped B-cell receptors in chronic lymphocytic leukemia.
Agathangelidis A; Vardi A; Baliakas P; Stamatopoulos K
Leuk Lymphoma; 2014 Oct; 55(10):2252-61. PubMed ID: 24397617
[TBL] [Abstract][Full Text] [Related]
14. Genetics and molecular biology of chronic lymphocytic leukemia.
Carney DA; Wierda WG
Curr Treat Options Oncol; 2005 May; 6(3):215-25. PubMed ID: 15869733
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in chronic lymphocytic leukemia.
Vyas N; Hassan A
Indian J Cancer; 2012; 49(1):137-43. PubMed ID: 22842181
[TBL] [Abstract][Full Text] [Related]
16. Murine genetically engineered and human xenograft models of chronic lymphocytic leukemia.
Chen SS; Chiorazzi N
Semin Hematol; 2014 Jul; 51(3):188-205. PubMed ID: 25048783
[TBL] [Abstract][Full Text] [Related]
17. Antigen receptor stereotypy in chronic lymphocytic leukemia.
Stamatopoulos K; Agathangelidis A; Rosenquist R; Ghia P
Leukemia; 2017 Feb; 31(2):282-291. PubMed ID: 27811850
[TBL] [Abstract][Full Text] [Related]
18. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.
Herishanu Y; Pérez-Galán P; Liu D; Biancotto A; Pittaluga S; Vire B; Gibellini F; Njuguna N; Lee E; Stennett L; Raghavachari N; Liu P; McCoy JP; Raffeld M; Stetler-Stevenson M; Yuan C; Sherry R; Arthur DC; Maric I; White T; Marti GE; Munson P; Wilson WH; Wiestner A
Blood; 2011 Jan; 117(2):563-74. PubMed ID: 20940416
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs and B cell receptor signaling in chronic lymphocytic leukemia.
Mraz M; Kipps TJ
Leuk Lymphoma; 2013 Aug; 54(8):1836-9. PubMed ID: 23597135
[TBL] [Abstract][Full Text] [Related]
20. Combined patterns of IGHV repertoire and cytogenetic/molecular alterations in monoclonal B lymphocytosis versus chronic lymphocytic leukemia.
Henriques A; Rodríguez-Caballero A; Nieto WG; Langerak AW; Criado I; Lécrevisse Q; González M; Pais ML; Paiva A; Almeida J; Orfao A
PLoS One; 2013; 8(7):e67751. PubMed ID: 23844084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
